We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

11 hedge funds and large institutions have $941K invested in Plus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more capital invested

Capital invested by funds: $168K → $941K (+$773K)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

38% more funds holding

Funds holding: 8 → 11 (+3)

0.13% more ownership

Funds ownership: 0% → 0.13% (+0.13%)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.2M
2
SM
Sabby Management
Florida
+$1.09M
3
CH
CVI Holdings
Delaware
+$376K
4
Citigroup
Citigroup
New York
+$325K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$275K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$9K
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$5K
3
UBS Group
UBS Group
Switzerland
-$3.61K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$3K
5
MOS
MGO One Seven
Ohio
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$389K +$1.09M +303 New
CH
2
CVI Holdings
Delaware
$134K +$376K +104 New
Renaissance Technologies
3
Renaissance Technologies
New York
$119K +$235K +65 +232%
Citigroup
4
Citigroup
New York
$115K +$325K +90 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$101K +$275K +76 +3,800%
ARTA
6
A.R.T. Advisors
New York
$41K +$116K +32 New
CS
7
Credit Suisse
Switzerland
$38K +$108K +30 New
BlackRock
8
BlackRock
New York
$2K – – –
Bank of America
9
Bank of America
North Carolina
$1K +$3.61K +1 New
QT
10
Quantamental Technologies
New York
$1K +$3.61K +1 New
AFM
11
Anson Funds Management
Texas
$428 +$1.2M +333 New
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3 – – –
Citadel Advisors
13
Citadel Advisors
Florida
– -$9K -2 Closed
Cambridge Investment Research Advisors
14
Cambridge Investment Research Advisors
Iowa
– -$5K -1 Closed
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$3K -1 Closed
MOS
16
MGO One Seven
Ohio
– -$2K -1 Closed
UBS Group
17
UBS Group
Switzerland
– -$3.61K -1 Closed

PSTV Hedge Fund Activity: Q3 2019 in Review

11 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2019, worth a combined $941K — up 460% from $168K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PSTV positions and 5 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.2M. The largest seller was Citadel Advisors, exiting entirely with an estimated $9K sold.

  • 11 institutional investors held Plus Therapeutics (PSTV) as of Q3 2019, up from 8 in Q2 2019.
  • Funds reported $941K of Plus Therapeutics stock for Q3 2019, up 460% quarter-over-quarter.
  • 8 funds opened new Plus Therapeutics positions in Q3 2019 and 5 closed out, a net change of +3 holders.
  • The largest Plus Therapeutics buyer in Q3 2019 was Anson Funds Management, an estimated $1.2M added.
  • The largest Plus Therapeutics seller in Q3 2019 was Citadel Advisors, an estimated $9K sold.

Based on aggregated 13F filings for Q3 2019.